One Wall Street analyst offers her opinion on whether BioMarin is a takeover candidate, as well as what a “blue-skies scenario” might entail for shareholders if everything goes their way.
One Wall Street analyst offers her opinion on whether BioMarin is a takeover candidate, as well as what a “blue-skies scenario” might entail for shareholders if everything goes their way.